Skip to content
EMBARC
Menu
  • HOME
  • ABOUT US
    • Management Committee
    • Acknowledgements
    • EMBARC Members
    • Transparency Notice
  • News
  • RESEARCH
    • The European Bronchiectasis Registry
    • The Biobank i.e., The EMBARC-BRIDGE Study
    • Clinical Trials
      • GREAT-2
      • AIR-NET
      • ESCAPE
      • Support of Non-EMBARC Clinical Trials
    • The Bronchiectasis Genetics Initiative
      • GECCO
    • Treatment Responses
      • Inhaled Antibiotics (ORBIT-3/4)
    • Imaging
    • Disease Definitions
    • Primary Ciliary Dyskinesia
    • Standards of Care
    • Patient Reported Outcomes
      • Chronic Airways Assessment Test (CAAT)
      • Bronchiectasis Health Questionnaire (BHQ)
      • Licensing for use of PROMs
    • Publications
  • EDUCATION
    • For Respiratory Professionals
      • Severity Assessment Calculator
    • For General Practitioners
  • Early Careers Area
  • INDUSTRY PARTNERS
  • Patient Partners & Resources
  • EMBARC REGISTRY
  • Contact Us
 
Copyright EMBARC ©2024
Web Site Supported by HIC Services (University of Dundee) ©2024
Youtube Linkedin